Rebalix
Logo JPMorganJPMorgan · sheet of 5 September 2026
ETF sheet · official issuer and register data

USD Emerging Markets Sovereign Bond UCITS ETF

JMBA · IE00BJ06C937 · class JPM - USD (acc) · USD · domicile Ireland
Bonds · Government USD · Emerging marketsSFDR art. 8
Index tracked: JPEIRWTR
TER
0.39%+ trans. 0.21%
Fund size
339 m EUR
Tracking difference
not computable
🇮🇹 tax rate
16.49%white list 70.44%
Replication
Physical (optimised)
Income
Accumulating
Duration
6.54 yrsmedium (3–7 years)
Launch 3 Dec 2019 · costs from the KID as of 2 Sept 2026 · 305 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
Investment Objective: The Sub-Fund aims to provide an exposure to the performance of bonds issued by the governments or quasi-government entities of emerging markets countries globally which are denominated in US Dollars. Investment Policy: The Sub-Fund pursues a passively managed (indextracking) strategy. The Sub-Fund aims to track the performance of the Index as closely as possible, regardless of whether the Index level rises or falls, while seeking to minimise as far as possible the tracking error between the Sub-Fund's performance and that of the…

Performance since series start (in euro) — base 100

3 Dec 20193 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202020212022202320242025202611284109
High 112 (25 Jun 2026) · low 84 (19 Mar 2020) · last 109. Past performance is not indicative of future results.

Returns in euro

1 year+6.4%
3 years+16.2%
5 years+7.5%
10 yearsseries too young
Since series start+8.6%

Risk · 1 / 3 / 5 years

Volatility (ann.)4.14%4.98%6.34%
Max drawdown−4.04%−5.29%−25.91%
Sharpe0.820.82-0.20
Sortino1.271.23-0.27
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · JMBA · IE00BJ06C9371
RebalixJMBA · IE00BJ06C937 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Fixed income — as declared by the issuer

Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 36.0%
Rating breakdown (% of fund)
AAA0.1%A11.6%BBB24.3%< BBB63.9%Cash and derivatives0.2%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 305 securities · top-10 weight = 12.6%
Countries (% of fund)
Turkey8.1%Brazil6.7%Colombia6.1%Dominican Republic6.0%South Africa5.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
JMBA · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 6 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · wl.fundsquare.net/serv/down-doc/request?cdClient=jpmorgan&isin=IE00BJ0
Factsheet · jp.techrules.com/rebrandingPDF/LoadPdf.aspx?ShareClassId=14084&country
Prospectus · wl.fundsquare.net/serv/down-doc/request?cdClient=jpmorgan&isin=IE00BJ0
The live sheet, always up to date
rebalix.com/en/etf/IE00BJ06C937
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · JMBA · IE00BJ06C9372